The nose key to winning the war against COVID-19
Researchers assess the respiratory mucosal immunity elicited by COVID-19 vaccination.
Stay updated with breaking news from S Specific Igm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers assess the respiratory mucosal immunity elicited by COVID-19 vaccination.
Antibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COVID-19, according to a study published in the peer-reviewed journal Viral Immunology.
A new study posted to the bioRxiv* preprint server followed the adaptive immune response in convalescent patients from Swedish and Italian cohorts—which had earlier shown long-lasting adaptive immune responses to the G614 strain—for 15 months. Here, specific antibody levels and neutralizing antibody titers were tested against variants of concern (VOCs).